Kazibwe, Andrew
Olal, Emmanuel
Ojok, Andrew Mijumbi
Kigongo, John Vianney
Kafumbe, Henry
Niwampeire, Maria Prima
Toskin, Charity Gloria
Ondo, Doreen
Nabitaka, Linda Kisaakye
Mwine, Patience
Kagimu, David
Lawino, Anna
Etukoit, Michael Bernard
Funding for this research was provided by:
Pfizer Foundation (9880)
Article History
Received: 14 February 2025
Accepted: 23 April 2025
First Online: 1 May 2025
Declarations
:
: We obtained ethical clearance for the study from The AIDS Support Organization (TASO) independent Research Ethics Committee (REC) (protocol number: TASO-2024-375). We also registered the protocol with the Uganda National Council for Science and Technology (Reference number: HS4414ES). In addition, we obtained administrative clearance to conduct the study from the Ministry of Health, and the respective District Health Offices.This evaluation was conducted in accordance with the Human Subjects Protections Guidelines in Uganda, (UNCST, July, 2014), and the ethical principles enshrined in the Declaration of Helsinki, (DOH, 2013). All participants provided written informed consent prior to data collection. No personally identifying data was linked to the data collection tools.
: Not applicable.
: The authors declare no competing interests.